4RG Stock Overview
DeepVerge plc, an environmental and life science artificial intelligent company, develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus, and toxins.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
DeepVerge plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0005 |
| 52 Week High | UK£0.11 |
| 52 Week Low | UK£0.0005 |
| Beta | 1.14 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.26% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4RG | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 1.1% |
| 1Y | -99.3% | -11.4% | 6.5% |
Return vs Industry: 4RG underperformed the German Life Sciences industry which returned -22.5% over the past year.
Return vs Market: 4RG underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 4RG volatility | |
|---|---|
| 4RG Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4RG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 4RG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 73 | Nigel Burton | www.deepverge.com |
DeepVerge plc, an environmental and life science artificial intelligent company, develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus, and toxins. The company offers Labskin, a commercially available lab-grown, full thickness human skin to support product research and development activities in the cosmetic, personal care, medical device, and pharmaceutical sectors; Rinocloud, a data infrastructure as a service that delivers secure intelligent store, share and search, encryption, and infrastructure technologies; and skin trust club, a skin health tracking using advanced sequencing, bioinformatics, and AI algorithms. It also provides regulated environmental toxicology services; human skin equivalent platform to validate and verify the safety and impact on client products for regulatory authority approval; AI and microbiome platform to facilitate clinical trials for skincare companies and remote test-kits for consumer skin; and monitoring and data analytics platform for real-time detection and identification of pathogens in water and wastewater treatment plants, drinking water, rivers, lakes, and reservoirs.
DeepVerge plc Fundamentals Summary
| 4RG fundamental statistics | |
|---|---|
| Market cap | €1.31m |
| Earnings (TTM) | -€2.83m |
| Revenue (TTM) | €14.27m |
0.1x
P/S Ratio-0.5x
P/E RatioIs 4RG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4RG income statement (TTM) | |
|---|---|
| Revenue | UK£12.41m |
| Cost of Revenue | UK£5.21m |
| Gross Profit | UK£7.20m |
| Other Expenses | UK£9.66m |
| Earnings | -UK£2.46m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0032 |
| Gross Margin | 58.00% |
| Net Profit Margin | -19.81% |
| Debt/Equity Ratio | 18.8% |
How did 4RG perform over the long term?
See historical performance and comparison